神经内分泌肿瘤中的血管生成抑制剂：终于走向成熟。 - Suppr

Angiogenesis inhibitors in neuroendocrine tumours: finally coming of age.

Kunz Pamela L

Department of Medicine, Division of Oncology, Yale School of Medicine, New Haven, CT 06520, USA.

Lancet Oncol. 2020 Nov;21(11):1395-1397. doi: 10.1016/S1470-2045(20)30560-X.

Abstract

摘要

Lancet Oncol. 2020 Nov;21(11):1395-1397. doi: 10.1016/S1470-2045(20)30560-X.

Endocrinol Metab Clin North Am. 2010 Dec;39(4):839-52. doi: 10.1016/j.ecl.2010.08.006.

J Mol Endocrinol. 2017 Jul;59(1):R77-R91. doi: 10.1530/JME-17-0029. Epub 2017 May 3.

Bull Cancer. 2007 Jul;94 Spec No:S159.

IDrugs. 2004 Jun;7(6):551-3.

Mol Cancer Ther. 2017 Nov;16(11):2502-2515. doi: 10.1158/1535-7163.MCT-17-0136. Epub 2017 Jul 20.

Anticancer Res. 2016 Oct;36(10):5025-5030. doi: 10.21873/anticanres.11071.

Dis Mon. 2013 Jan;59(1):5-19. doi: 10.1016/j.disamonth.2012.10.002.

Oncol Rep. 2009 Mar;21(3):769-75.

Best Pract Res Clin Endocrinol Metab. 2007 Mar;21(1):163-72. doi: 10.1016/j.beem.2007.01.006.

Methods Mol Biol. 2022;2524:457-469. doi: 10.1007/978-1-0716-2453-1_34.

Biology (Basel). 2021 Jul 20;10(7):688. doi: 10.3390/biology10070688.

20分钟写一篇综述，助力文献阅读效率提升50倍。

大模型驱动的PubMed中文搜索引擎

学术文献翻译模型，支持多种主流文档格式。